Research ArticleClinical Studies
Comparative Efficacy of Combination Therapy of Ipilimumab Plus Nivolumab for Non-clear Cell Renal Cell Carcinoma
YUKARI BANDO, JUNYA FURUKAWA, YASUYOSHI OKAMURA, TAKUTO HARA, TOMOAKI TERAKAWA, YUZO NAKANO and MASATO FUJISAWA
Anticancer Research February 2022, 42 (2) 973-979; DOI: https://doi.org/10.21873/anticanres.15557